The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 26th 2025
New research confirms hydroxyurea's long-term effectiveness in reducing hospital visits for children with sickle cell anemia, supporting its use as standard treatment.
Prescriptions for Extended-Release Drugs Cost Health Care System Billions
March 4th 2020Using the 2012 to 2017 Medicare Part D Drug Event and Medicaid Spending and Utilization data sets, the researchers analyzed 20 extended-release drugs with 37 Medicare formulations and 36 Medicaid formulations. The analyses were conducted from January to December 2019.
Read More
New Genes Controlling HIV Infection Discovered That Could Help Make Predictions About Pharmacy
March 4th 2020Scientists at the Gladstone Institutes have cataloged host proteins that physically bind to HIV proteins, which identify human proteins that the virus can use to infect cells and spread.
Read More
Colorado Aims to Let Pharmacists Write Own Prescriptions for HIV Prevention Drugs
March 3rd 2020The bill is intended to "prevent a health insurance carrier from requiring a covered person to undergo step therapy or to receive prior authorization before receiving HIV infection prevention drugs."
Read More
U=U Continues to Unite HIV Community, Dismantle Stigma Around the Epidemic
March 3rd 2020The Undectectable = Untransmittable (U=U) campaign started in early 2016 and has been sharing the message to dismantle the stigma surrounding HIV ever since. More than 970 community partners from 101 countries have come together to clear up the confusion about the science behind U=U.
Read More
4 Pharmacy Groups Document Support in Supreme Court Case Seeking to Limit PBMs
March 3rd 2020The National Community Pharmacists Association, the Arkansas Pharmacists Association, the American Pharmacists Association, and the National Alliance of State Pharmacy Associations took the joint action of filing an amicus brief in the Supreme Court case [Arkansas Attorney General Leslie] Rutledge v. the Pharmaceutical Care Management Association, scheduled to be heard in Washington, DC on April 27, 2020.
Read More
Report: Increases in Drug Rebates Associated with Rise in list Prices
February 27th 2020According to a new report from the Leonard D. Schaeffer Center for Health Policy and Economics, a $1 increase in drug rebates was associated with a $1.17 rise in list prices, hurting uninsured patients who pay list prices and insured patients who pay coinsurance and deductibles based on list prices.
Read More
Tip of the Week: Avoiding Legal, Financial Difficulties With Ethical Decisions
February 27th 2020In the matter of California State Board of Pharmacy vs Pacifica Pharmacy and Thang Tran, action was taken by the board against a pharmacist accused of poor oversight, and judgment over occurrences at a community pharmacy under his watch.
Read More
Survey Shows Patients Are Unaware of Resources Offered by Manufacturers of Medications
February 26th 2020A recent patient survey conducted by Human Care Services uncovered a genuine significant desire from patients for help from drug manufacturers in managing their conditions and drug regimens.
Read More
Awaiting Supreme Court Ruling on Regulations, States Aim to Legislate PBMs On Their Own
February 25th 2020As the Supreme Court prepares to hear oral arguments in Rutledge v. Pharmaceutical Care Management Association (PCMA), several states are moving forward with their own legislation to limit the influence of pharmacy benefit managers (PBMs) in managed care organizations.
Read More
Religious Vaccine Exemption Bills Spark Debate Across the United States
February 25th 2020Ongoing legislative efforts to remove religious exemptions from vaccinations have led to protests by vocal anti-vaccination advocates, who claim that the bills limit the right of parents to care for their children.
Read More
Alternative Options for Anti-Opioid Addiction Medications in Health Care
February 25th 2020In recent years, drugmakers have been accused of pushing opioid prescriptions on physicians across the United States and allegedly downplaying the risks of addiction. Meanwhile, governments feel that distributors and pharmacies have turned a blind eye to suspicious orders and failed to meet government requirements on painkillers.
Read More